(Q44505735)

3 December 2017

title

Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastoma (English)

1 reference

3 December 2017

Juraj Hlavaty

1

1 reference

3 December 2017

Gerrit Jandl

2

1 reference

3 December 2017

Melissa Liszt

3

1 reference

3 December 2017

Helga Petznek

4

1 reference

3 December 2017

Marielle König-Schuster

5

1 reference

3 December 2017

Jenny Sedlak

6

1 reference

3 December 2017

Monika Egerbacher

7

1 reference

3 December 2017

Jakob Weissenberger

8

1 reference

3 December 2017

Brian Salmons

9

1 reference

3 December 2017

Walter H Günzburg

10

1 reference

3 December 2017

Matthias Renner

11

1 reference

3 December 2017

publication date

11 July 2010

1 reference

Journal of Neuro-Oncology

3 December 2017

published in

1 reference

3 December 2017

volume

102

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

59-69

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-010-0295-5

3 December 2017

exact match

0 references

cites work

Brain tumors: molecular biology and targeted therapies

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Adeno-associated virus vector containing the herpes simplex virus thymidine kinase gene causes complete regression of intracerebrally implanted human gliomas in mice, in conjunction with ganciclovir administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Clinical trials with retrovirus mediated gene therapy--what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Replicative retroviral vectors for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Replication-competent vectors and empty virus-like particles: new retroviral vector designs for cancer gene therapy or vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Replication-competent retrovirus vectors for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

A highly invasive human glioblastoma pre-clinical model for testing therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Mouse models of brain tumors and their applications in preclinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Orthotopic transplantation of v-src-expressing glioma cell lines into immunocompetent mice: establishment of a new transplantable in vivo model for malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Biochemically differentiated mouse glial lines carrying a nervous system specific cell surface antigen (NS-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Morphological studies of rat brain tumors induced by N-nitrosomethylurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Rapid identification of viable retrovirus-transduced cells using the green fluorescent protein as a marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Pharmacological Studies with 5-Fluorocytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Analysis of 4070A envelope levels in retroviral preparations and effect on target cell transduction efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Migration and invasion in brain neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Diffuse glioma growth: a guerilla war

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0295-5

Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model

21 January 2018

1 reference

12 December 2020

Characterization of Tu-2449, a glioma cell line derived from a spontaneous tumor in GFAP-v-src-transgenic mice: comparison with established murine glioma cell lines.

1 reference

12 December 2020

Standardization of an orthotopic mouse brain tumor model following transplantation of CT-2A astrocytoma cells

1 reference

12 December 2020

A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses

1 reference

12 December 2020

Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene--a phase I/II clinical protocol.

1 reference

12 December 2020

Effects of sequences of prokaryotic origin on titer and transgene expression in retroviral vectors

1 reference

12 December 2020

Characterization of two new permanent glioma cell lines 8-MG-BA and 42-MG-BA.

1 reference

12 December 2020

Vaccinia virus-mediated expression of wild-type p53 suppresses glioma cell growth and induces apoptosis.

1 reference

12 December 2020

Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.

1 reference

12 December 2020

1 reference

12 December 2020

Studies on the chemotherapy of experimental brain tumors: development of an experimental model

1 reference

12 December 2020

Oncolytic adenoviral therapy for glioblastoma multiforme

1 reference

12 December 2020

The nature of gliomas as revealed by animal experimentation.

1 reference

12 December 2020

10.1007/S11060-010-0295-5

Identifiers

DOI

1 reference

3 December 2017

1 reference